Miranda Jayne Toledano - Jun 25, 2021 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Director
Signature
Patrick J. Kinney, Jr., as attorney-in-fact for Miranda Toledano
Stock symbol
CMPX
Transactions as of
Jun 25, 2021
Transactions value $
$0
Form type
4
Date filed
6/29/2021, 02:31 PM
Next filing
Sep 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPX Common Stock, $.0001 Par Value Other +1.79M 1.79M Jun 25, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jun 25, 2021 Common Stock, $.0001 Par Value 50K $4.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired 1,791,549 shares of the issuer's common stock as consideration in connection with the acquisition of TRIGR Therapeutics, Inc. by the issuer. The merger agreement, which was entered into on May 13, 2021, placed a negotiated value on the issuer's common stock of $5.85 a share. Of the 1,791,549 shares issued to the reporting person in the merger, 283,648 shares are currently being held in escrow and are subject to forfeiture for the purposes described in the merger agreement.
F2 The option has a term of 10 years and vest in equal monthly installments over the 48 month period commencing on July 25, 2021.